AU4672301A - Medical combinations comprising formoterol and fluticasone proprionate - Google Patents

Medical combinations comprising formoterol and fluticasone proprionate

Info

Publication number
AU4672301A
AU4672301A AU46723/01A AU4672301A AU4672301A AU 4672301 A AU4672301 A AU 4672301A AU 46723/01 A AU46723/01 A AU 46723/01A AU 4672301 A AU4672301 A AU 4672301A AU 4672301 A AU4672301 A AU 4672301A
Authority
AU
Australia
Prior art keywords
formoterol
fluticasone proprionate
medical combinations
medical
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46723/01A
Inventor
Ronique Nichele Garrett
Brian Charles Gavin
Trevor Charles Roche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU4672301A publication Critical patent/AU4672301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU46723/01A 2000-04-18 2001-04-11 Medical combinations comprising formoterol and fluticasone proprionate Abandoned AU4672301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0009591 2000-04-18
GBGB0009591.9A GB0009591D0 (en) 2000-04-18 2000-04-18 Medical combinations
PCT/GB2001/001649 WO2001078745A1 (en) 2000-04-18 2001-04-11 Medical combinations comprising formoterol and fluticasone proprionate

Publications (1)

Publication Number Publication Date
AU4672301A true AU4672301A (en) 2001-10-30

Family

ID=9890176

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46723/01A Abandoned AU4672301A (en) 2000-04-18 2001-04-11 Medical combinations comprising formoterol and fluticasone proprionate

Country Status (3)

Country Link
AU (1) AU4672301A (en)
GB (1) GB0009591D0 (en)
WO (1) WO2001078745A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002244211B2 (en) * 2001-04-17 2007-07-05 Dey, L.P. Aerosol Compositions Containing Formoterol for Delivery to the Lungs via Nebulization
AU2002250199B2 (en) * 2001-04-17 2007-07-26 Dey, L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US20020132803A1 (en) * 2001-01-05 2002-09-19 Mahendra Dedhiya Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus
GB0106031D0 (en) * 2001-03-12 2001-05-02 Glaxo Group Ltd Use
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
DE10130371A1 (en) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics, corticosteroids and betamimetics
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
DE10216429A1 (en) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide
US7084153B2 (en) 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
EP2322243A1 (en) * 2002-08-29 2011-05-18 Cipla Ltd. Pharmaceutical products and compositions comprising formoterol, ciclesonide and tiotropium
SE527069C2 (en) 2003-06-19 2005-12-13 Mederio Ag Method and apparatus for administering drug powder
SE527191C2 (en) * 2003-06-19 2006-01-17 Microdrug Ag Inhaler device and combined doses of tiotropium and fluticasone
DE10347994A1 (en) 2003-10-15 2005-06-16 Pari GmbH Spezialisten für effektive Inhalation Aqueous aerosol preparation
DE602005026225D1 (en) * 2004-03-12 2011-03-24 Cipla Ltd Sterilization process for steroids
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
TR201000622A2 (en) * 2010-01-28 2011-08-22 Bi̇lgi̇ç Mahmut Pharmaceutical combinations containing tiotropium.
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
WO2011093811A2 (en) * 2010-01-29 2011-08-04 Mahmut Bilgic Pharmaceutical preparations comprising formoterol and fluticasone
CA2814445A1 (en) 2010-10-12 2012-04-19 Cipla Limited Pharmaceutical composition
MX2014011576A (en) 2012-04-11 2014-11-21 Cipla Ltd Pharmaceutical composition comprising arformoterol and fluticasone furoate.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1291A (en) * 1980-02-15 1985-10-18 Glaxo Group Ltd Androstane 17 beta carbothioates
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
ES2178015T3 (en) * 1996-11-11 2002-12-16 Sepracor Inc OPTICALLY PURE FORMOTEROL ISOMER PREPARATION PROCEDURE.
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002244211B2 (en) * 2001-04-17 2007-07-05 Dey, L.P. Aerosol Compositions Containing Formoterol for Delivery to the Lungs via Nebulization
AU2002250199B2 (en) * 2001-04-17 2007-07-26 Dey, L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof

Also Published As

Publication number Publication date
WO2001078745A1 (en) 2001-10-25
GB0009591D0 (en) 2000-06-07

Similar Documents

Publication Publication Date Title
AU4672301A (en) Medical combinations comprising formoterol and fluticasone proprionate
AU4671801A (en) Medical combinations comprising tiotropium and fluticasone proprionate
AU4671601A (en) Medical combinations comprising formoterol and budesonide
AU4853701A (en) Medical combinations comprising tiotropium and budesonide
AU4854001A (en) Medical combinations comprising tiotropium and mometasone
AU4671501A (en) Medical combinations comprising tiotropium and rofleponide
HK1042429A1 (en) Combinations of formoterol and fluticasone propionate for asthma.
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2001253411A1 (en) Medical dressing assembly and associated method of using the same
AU2002243246A1 (en) Cddo-compounds and combination therapies thereof
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU5468301A (en) Ablation and imaging catheter
AU2002354410A1 (en) Triazole compound and medicinal use thereof
AU2002312315A1 (en) Microfabricated surgical devices and methods of making the same
AU4854101A (en) Medical combinations comprising formoterol and mometasone
PL365582A1 (en) Use of salmeterol and fluticasone propionate combination
AU4853801A (en) Medical combination comprising salmeterol and budesonide
AU2002237400A1 (en) Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate
AU2002234773A1 (en) Pharmaceutically effective ginsenosides and their use
AU4853601A (en) Medical combinations comprising mometasone and salmeterol
AU2002210916A1 (en) Endoscope attachment and endoscope
AU6710900A (en) Field emitters and devices
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU4671701A (en) Medical compositions comprising (r,r)-formoterol and rofleponide
AU2001247841A1 (en) Medical procedure

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase